Oncology & Cancer

Drug mechanism opens door for new anti-cancer immunotherapies

Researchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immune cell function, that could be exploited using new anti-cancer immunotherapies.

Medical economics

Time for a new approach to aging, say researchers

We usually associate aging with a shrinking life span, sickness and death. The difficulty of imagining ourselves as old means that we go to great lengths to avoid planning for later life. Yet researchers argue that we have ...

page 3 from 13